Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Pharmacokinetics of 2% TD1414 Cream in Adults With Secondarily Infected Traumatic Lesions (SITL) or Impetigo

NCT00758862 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT00758862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00758862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Pharmacokinetics of 2% TD1414 Cream in Adults With Secondarily Infected Traumatic Lesions (SITL) or Impetigo
Lead sponsor
LEO Pharma
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2008
Completion date
February 28, 2009
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

impetigo, secondarily infected traumatic lesions (sitl)